Share This Author
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
- E. von Elm, D. Altman, M. Egger, S. Pocock, P. Gøtzsche, J. Vandenbroucke
- MedicinePreventive medicine
- 1 November 2007
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Initiative developed recommendations on what should be included in an accurate and complete report of an observational study, resulting in a checklist of 22 items that relate to the title, abstract, introduction, methods, results, and discussion sections of articles.
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.
In patients with severe aortic stenosis who were not suitable candidates for surgery, TAVI, as compared with standard therapy, significantly reduced the rates of death from any cause, the composite end point of deathFrom any cause or repeat hospitalization, and cardiac symptoms, despite the higher incidence of major strokes and major vascular events.
Transcatheter versus surgical aortic-valve replacement in high-risk patients.
In high-risk patients with severe aortic stenosis, transcatheter and surgical procedures for aorti-valve replacement were associated with similar rates of survival at 1 year, although there were important differences in periprocedural risks.
Group sequential methods in the design and analysis of clinical trials
- S. Pocock
- 1 August 1977
SUMMARY In clinical trials with sequential patient entry, fixed sample size designs are unjustified on ethical grounds and sequential designs are often impracticable. One solution is a group…
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
The STROBE Statement provides guidance to authors about how to improve the reporting of observational studies and facilitates critical appraisal and interpretation of studies by reviewers, journal editors and readers.
Eplerenone in patients with systolic heart failure and mild symptoms.
Eplerenone, as compared with placebo, reduced both the risk of death and therisk of hospitalization among patients with systolic heart failure and mild symptoms.
Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial.
A new general procedure for treatment assignment is described which concentrates on minimizing imbalance in the distributions of treatment numbers within the levels of each individual prognostic factor.
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Those in the empagliflozin group had a lower risk of cardiovascular death or hospitalization for heart failure than those in the placebo group, regardless of the presence or absence of diabetes.
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
In the time-to-event analysis, the rate of the first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, orNonfatal stroke among patients with type 2 diabetes mellitus was lower with liraglutide than with placebo.
Epidemiologic Research: Principles and Quantitative Methods.
Key Issues in Epidemiologic Research: An Overview. OBJECTIVES AND METHODS OR EPIDEMIOLOGIC RESEARCH. Fundamentals of Epidemiologic Research. Types of Epidemiologic Research. Design Options in…